BeStock  

ePlus PLUS

US equityMarket cap rank #2648Software - Application
$93.02 −$0.38 (-0.41%)
Pre-market · Oct 6, 4:00 am ET · After hours $93.02 0.00%
Open$93.40
Prev close$93.40
Day range$91.95 – $94.13
Volume268.9K
Market cap$2.43B
P/E (TTM)20.3
Dividend yield1.10%

PLUS Stock News

Headlines matching ePlus or the PLUS ticker, most recent first.

  • Deutsche Bank Initiates CANAL PLUS SA(CNALF.US) With Buy Rating, Announces Target Price $4.47Market news · 9 Sep 2026
  • Nvidia Is Approaching a Breakout Level. Plus, What We Want to See From MicronCNBC · 30 Sep 2026
  • William Blair Maintains EPlus(PLUS.US) With Buy RatingMarket news · 30 Sep 2026
  • Scotiabank Maintains 5N PLUS INC(FPLSF.US) With Buy Rating, Raises Target Price to $26.1Market news · 28 Sep 2026
  • 5N Plus Inc. Is Maintained at Sector Outperform by Scotia CapitalDow Jones · 28 Sep 2026
  • 5N Plus Inc. Price Target Raised to C$37.00/Share From C$35.00 by Scotia CapitalDow Jones · 28 Sep 2026
  • Ying'en Bio-B (09606.HK): Core product registrations and clinical progress are being steadily realized; the ADC plus second-generation IO combination therapy is highly anticipated.Essence Securities · 2 Sep 2026
  • Truist Financial Maintains Travel Plus Leisure(TNL.US) With Buy Rating, Maintains Target Price $86Market news · 15 Sep 2026
  • Truist Financial Maintains Travel Plus Leisure(TNL.US) With Buy Rating, Announces Target Price $86Market news · 10 Sep 2026
  • Sungrow (300274): A leading player in solar-plus-storage is accelerating its AIDC deployment, with a steady stream of new products for large-scale energy storage, commercial applications, and industrial use.Western Securities · 30 Aug 2026
  • Lenovo Group (00992.HK): The cloud-plus-edge AI server upcycle continues, and ISG's profitability is expected to improve significantly.Kaiyuan Securities · 28 Aug 2026
  • CanFang Bio (9926.HK): In a head-to-head Phase III trial in first-line biliary tract cancer, AK112 demonstrated significantly superior overall survival compared to durvalumab plus chemotherapy, further validating its potential.China Securities Co., Ltd. · 27 Aug 2026
  • Plus Alpha Consulting: "AI Plus Talk" has shortened Yamato Contact Service's new‑employee training from two weeks to three days—leveraging AI‑powered role‑plays to accelerate workforce readiness and enhance service quality.JPX · 6 Oct 2026
  • Reported Sunday, Suncor To Sell Non-Core Offshore Assets For C$1.2B Cash Plus Up To C$350M Contingent, Lifts Monthly Buybacks To C$750M From C$500MBenzinga · 5 Oct 2026
  • A.PLUS GROUP: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026HKEX · 2 Oct 2026

Discussion

No comments yet — be the first to weigh in on PLUS.

Leave a comment

Scroll to Top